Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-035106
Filing Date
2013-06-14
Accepted
2013-06-14 21:30:58
Documents
1
Period of Report
2013-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd383589.html 4  
1 FORM 4 rrd383589.xml 4 4698
  Complete submission text file 0001181431-13-035106.txt   6150
Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001411879 (see all company filings)

EIN.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address C/O BIO-QUANT, INC. 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO CA 92121
Business Address
Damaj Bassam (Reporting) CIK: 0001478733 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52991 | Film No.: 13915513